C9 Antibodies

Santa Cruz Biotechnology offers a broad range of C9 Antibodies for studying complement component C9 protein. Monoclonal C9 Antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C9 is a crucial component of the complement system, playing a significant role in the immune response by forming the membrane attack complex that can lyse pathogens. Understanding C9 function is essential for elucidating its involvement in various diseases, including autoimmune disorders and infections. The study of complement component C9 can provide insights into therapeutic targets and the regulation of immune responses. Research into C9 has revealed its importance in maintaining immune system homeostasis and protecting against pathogenic threats. Investigating C9's role in disease progression helps identify potential treatment strategies. Ongoing studies continue to uncover new aspects of C9's biological functions and disease associations. Santa Cruz Biotechnology monoclonal C9 Antibodies enable researchers worldwide to advance scientific understanding of immune system regulation and disease mechanisms.